News & Articles

Paper published in Frontline Gastroenterology outlines new quality standards and benchmarking framework for inflammatory bowel disease

Drop by and see SelectScience on booth #724 at this year's AACC conference in Anaheim, California, from August 4-8

Access to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals

Startup uses brain stimulation headset and therapy app to treat depression

Rigaku Oxford Diffraction is exhibitor and sponsor at the 2019 ACA Annual Meeting in Covington

The off-the-shelf diploid library includes over 2,800 single clonal knockout (KO) cell lines, targeting over 2,600 genes

Joint chemical identification technologies are integrated into a single handheld solution to deliver advanced automated explosive detection and chemical analysis capabilities

Arcis technology is designed to enable stabilization of microRNA biomarkers for early disease diagnosis

Understanding how insects navigate using the sun and daylight has potential to aid robot guidance system development

New industrial solutions from the partnership include in-line X-ray semiconductor metrology with microfocus mirror optics

The 7th International Conference on Advanced Applied Raman Spectroscopy attracted top scientists across the field

Decision enables human identification labs to upload genetic profiles to national database using Applied Biosystems Precision ID panel for mitochondrial DNA analysis

Deal brings single-cell genomics to China and accelerates Mission Bio’s mission to predict and prevent cancer relapse on a global scale

New partnership to advance Nosopharm’s lead candidate to clinical stage

Phase 1 trial scheduled for early 2020 will be first CAR-T cell therapy clinical trial to employ SMARTvector technology

Planned acquisition aims to strengthen leadership position in growing cell analysis segment

Rigaku presents its X-ray analytical instrumentation for the semiconductor industry at SEMICON West 2019

inStem’s Centre for Chemical Biology and Therapeutics to work with PhoreMost to progress selected targets